12-56471836-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_013267.4(GLS2):c.1589G>A(p.Gly530Glu) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,613,700 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_013267.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GLS2 | NM_013267.4 | c.1589G>A | p.Gly530Glu | missense_variant, splice_region_variant | 17/18 | ENST00000311966.9 | |
SPRYD4 | NM_207344.4 | c.*2259C>T | 3_prime_UTR_variant | 2/2 | ENST00000338146.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GLS2 | ENST00000311966.9 | c.1589G>A | p.Gly530Glu | missense_variant, splice_region_variant | 17/18 | 1 | NM_013267.4 | P1 | |
SPRYD4 | ENST00000338146.7 | c.*2259C>T | 3_prime_UTR_variant | 2/2 | 1 | NM_207344.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152094Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251106Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135700
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461606Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727100
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152094Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74292
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 31, 2023 | The c.1589G>A (p.G530E) alteration is located in exon 17 (coding exon 17) of the GLS2 gene. This alteration results from a G to A substitution at nucleotide position 1589, causing the glycine (G) at amino acid position 530 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at